XML 57 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Long-Term Investments (Details 4) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Net sales $ 226,513 $ 191,782 $ 305,299 $ 404,024
Gross profit 222,277 178,430 297,104 389,173
Share of losses from investments accounted for using the equity method $ (38,937) (38,937)
BioFirst [Member]        
Net sales     25,730 20,446
Gross profit     3,261 4,214
Net loss     (832,818) (543,582)
Share of losses from investments accounted for using the equity method     (180,067) (117,424)
Rgene [Member]        
Net sales     2,237
Gross profit     (331,565)
Net loss     (391,686) (49,896)
Share of losses from investments accounted for using the equity method